Pnc Financial Services Group, Inc. 4 D Molecular Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,124 shares of FDMT stock, worth $33,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,124
Previous 5,494
66.07%
Holding current value
$33,120
Previous $59,000
15.25%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding FDMT
# of Institutions
146Shares Held
46.5MCall Options Held
121KPut Options Held
33.2K-
Black Rock Inc. New York, NY4.9MShares$17.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$16.6 Million0.41% of portfolio
-
Goldman Sachs Group Inc New York, NY4.27MShares$15.5 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.95MShares$10.7 Million2.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$10.4 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $118M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...